Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 27/07/2026🚨 This is BIG! The Thai FDA has approved NUZOLVENCE® (zoliflodacin), a first-in-class oral antibiotic for the treatment of uncomplicated urogenital gonorrhoea, just 6 months after its initial approval by the US FDA. 🔗 gardp.org/thai-fda-app... 122
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 27/07/2026🌍 With Thailand being only the second country to approve zoliflodacin, this approval sets a new benchmark for how rapidly novel antibiotics can reach LMICs and demonstrates how public-private R&D partnerships can accelerate innovation and equitable access in the global AMR response. 100
